UK-based confectioner Cadbury Schweppes has confirmed that, following shareholder and regulatory approvals, it has completed its acquisition of Adams from Pfizer for US$4.2bn.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Cadbury said that Cadbury Schweppes and Adams’ confectionery businesses in the Americas will be integrated into a new unit, Americas Confectionery. Elsewhere, Adams operations will be integrated into Cadbury Schweppes’ Europe, Middle East & Africa and Asia Pacific regions.
With the acquisition, Cadbury gains Adams’ four main brands – Halls medicated confectionery, Trident sugarfree gum, the Bubbas bubblegum range and Dentyne Ice chewing gum – which together account for over 70% of Adams’ sales.
